Sepsis Diagnostics Market Set to Grow at 9.1% CAGR to 2023 - Emerging Trends, Industry Forecast, Segmentation and Top Technologies

Sepsis diagnostic market is segmented into microbiology, immunoassays, molecular diagnostics, flow cytometry, microfluidics, and biomarkers. In 2019, the microbiology segment accounted for the largest share of the sepsis diagnostic market.

Sepsis diagnostics market research report has focused on various levels of analysis—market ranking analysis of top players and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging segments of the sepsis diagnostics market, and high-growth regions and their drivers, restraints, challenges, and opportunities.

Browse the Sample Papers of Sepsis Diagnostics Market
Spread across 193 Pages,
Profiling 15 Company Profiles and
Supported with 130 Tables and 41 Figures
Now available at www.reportsnreports.com/contacts/requestsample.aspx?name=690207 .

The global sepsis diagnostic market is projected to reach USD 613.9 Million by 2023 from USD 396.6 Million in 2018, at a CAGR of 9.1% during forecast period. Factors such as rising prevalence of sepsis across the globe, increasing geriatric population, growing government initiatives for creating sepsis awareness, and high incidence of hospital-acquired infections are expected to drive demand for sepsis diagnosis during study period.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help firms garner greater market shares.

Geographically, the sepsis diagnostics market is segmented into North America, Europe, Asia Pacific, and RoW. Asia Pacific is expected to register the highest growth rate during the forecast period d ue to the high prevalence of sepsis, increasing number of surgical procedures, growing number of clinical studies, and developing healthcare infrastructure in this region.
Click Here for More Information on Sepsis Diagnostic Market with Forecast and Company Profiles, Top Trends at http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=690207 .

The sepsis diagnostic market is categorized into two segments, namely, conventional diagnostics and automated diagnostics. The automated diagnostics segment is expected to grow at the highest CAGR from 2018 to 2023. Accurate detection of positive blood cultures, quick turnaround time, and reduced risk of contamination is contributing to the growth of this segment.

The major players of sepsis diagnostics market are bioMérieux (France), T2 Biosystems (US), Luminex (US), Thermo Fisher Scientific (US), Bruker (US), Abbott (US), Roche (Switzerland), Danaher (US), Becton, Dickinson, and Company (US), EKF Diagnostics (UK), Immunexpress (Australia), Response Biomedical (Canada), Axis-Shield Diagnostics (UK), CytoSorbents (US), and Mitsubishi Chemical Europe (Germany).

Connect Here for Discount on “Sepsis Diagnostics Market by Technology (Microbiology, Molecular Diagnostic, Immunoassay, Biomarkers), Product (Blood Culture Media, Instruments), Method (Automated), Test Type (Lab, POC), Pathogen (Bacterial, Fungal), End-User - Global Forecast to 2023” report at http://www.reportsnreports.com/contacts/discount.aspx?name=690207 .

The global sepsis diagnostics market is segmented based on technology, product, method, usability, pathogen, and geography. The market by technology is divided into microbiology, molecular diagnostics, immunoassays, and flow cytometry. By product, it is categorized into blood culture media, instruments, assays & reagents, and software.

Contact Info:
Name: Vishal
Email: Send Email
Organization: ReportsandReports
Address: Tower B5, Office 101, Magarpatta City SEZ, Pune-411013, India
Phone: +1 888 391 5441
Website: https://www.reportsnreports.com/reports/690207-sepsis-diagnostics-market-by-technology-molecular-diagnostics-microbiology-immunoassay-product-instrument-blood-culture-media-method-conventional-automated-usability-laboratory-poc-pathogen-bacterial-fungal-global-forecast-to-2021.html

Release ID: 496916